CTLA-4 is a T cell antigen that is structurally related to CD28 and serves as a high affinity ligand for the B cell antigen B7-1/2. Unlike CD28, the function of CTLA-4 is unclear, although reports have implicated the antigen in the costimulation of T cells. Recently, phosphatidylinositol 3-kinase (PI 3-kinase) has been implicated in the costimulatory function of CD28 by virtue of its ability to bind to a pYMNM motif within the cytoplasmic tail of the antigen. In this study, we show that CTLA-4 can also associate with PI 3-kinase as detected by lipid kinase analysis and immunoblotting with anti-p85 antiserum. High pressure liquid chromatographic separation of deacylated lipids showed the presence of a peak corresponding to PI-3-P. Anti-CTLA-4 ligation of the receptor induced a significant increase in the levels of precipitable PI 3-kinase activity. Peptide binding studies revealed that the NH2- and COOH-terminal SH2 domains of p85 bind the CTLA-4 cytoplasmic pYVKM motif with an affinity (ID50: 0.6 and 0.04 microM), that is similar to CD28. CTLA-4 binding to PI 3-kinase provides further evidence that CTLA-4 is not an inert counterreceptor, but rather is coupled to an intracellular signaling molecule with the capacity to regulate cell growth.
Skip Nav Destination
Article navigation
1 January 1995
Article|
January 01 1995
CTLA-4 binding to the lipid kinase phosphatidylinositol 3-kinase in T cells.
H Schneider,
H Schneider
Division of Tumor Immunology, Dana-Farber Cancer Institute, Boston, Massachusetts 02215.
Search for other works by this author on:
K V Prasad,
K V Prasad
Division of Tumor Immunology, Dana-Farber Cancer Institute, Boston, Massachusetts 02215.
Search for other works by this author on:
S E Shoelson,
S E Shoelson
Division of Tumor Immunology, Dana-Farber Cancer Institute, Boston, Massachusetts 02215.
Search for other works by this author on:
C E Rudd
C E Rudd
Division of Tumor Immunology, Dana-Farber Cancer Institute, Boston, Massachusetts 02215.
Search for other works by this author on:
H Schneider
Division of Tumor Immunology, Dana-Farber Cancer Institute, Boston, Massachusetts 02215.
K V Prasad
Division of Tumor Immunology, Dana-Farber Cancer Institute, Boston, Massachusetts 02215.
S E Shoelson
Division of Tumor Immunology, Dana-Farber Cancer Institute, Boston, Massachusetts 02215.
C E Rudd
Division of Tumor Immunology, Dana-Farber Cancer Institute, Boston, Massachusetts 02215.
Online ISSN: 1540-9538
Print ISSN: 0022-1007
J Exp Med (1995) 181 (1): 351–355.
Citation
H Schneider, K V Prasad, S E Shoelson, C E Rudd; CTLA-4 binding to the lipid kinase phosphatidylinositol 3-kinase in T cells.. J Exp Med 1 January 1995; 181 (1): 351–355. doi: https://doi.org/10.1084/jem.181.1.351
Download citation file:
Sign in
Don't already have an account? Register
Client Account
You could not be signed in. Please check your email address / username and password and try again.
Could not validate captcha. Please try again.
Sign in via your Institution
Sign in via your InstitutionSuggested Content
Email alerts
Advertisement